TEPOTINIB
Manner of administration:Oral
Restriction (Streamlined authority code: 13434)
Indication: Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer
(NSCLC)
Treatment phase: Initial treatment
Restriction (Streamlined authority code: 13441)
Indication: Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer
(NSCLC)
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 60 | # of repeats: 5 | DPMQ: $9,105.13 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tepmetko | |||||